Impact Biomedical Files 8-K: Other Events Reported
Ticker: IBO · Form: 8-K · Filed: Oct 27, 2025 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 8-K |
| Filed Date | Oct 27, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: other-events, sec-filing
TL;DR
IMPACT BIOMEDICAL INC. filed an 8-K for 'Other Events' on 10/24/2025. Details TBD.
AI Summary
Impact Biomedical Inc. filed an 8-K on October 27, 2025, reporting an "Other Events" item as of October 24, 2025. The filing does not contain specific details about the nature of these events or any associated financial figures.
Why It Matters
This filing indicates that Impact Biomedical Inc. has reported an event requiring disclosure to the SEC. Investors should look for further details to understand the potential impact on the company.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without immediate disclosed details, creating uncertainty for investors.
Key Players & Entities
- Impact Biomedical Inc. (company) — Registrant
- October 24, 2025 (date) — Date of earliest event reported
- October 27, 2025 (date) — Filing Date
- Nevada (jurisdiction) — State of incorporation
- Houston, TX (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Impact Biomedical Inc.?
The provided filing excerpt does not specify the nature of the 'Other Events' reported by Impact Biomedical Inc. as of October 24, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 24, 2025.
What is the filing date of this 8-K report?
This 8-K report was filed on October 27, 2025.
In which state is Impact Biomedical Inc. incorporated?
Impact Biomedical Inc. is incorporated in Nevada.
What is the business address of Impact Biomedical Inc.?
The business address of Impact Biomedical Inc. is 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.
Filing Stats: 489 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-10-27 16:05:40
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share N/A N/A Indic
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-25-019734.txt ( ) — 193KB
- ibo-20251024.xsd (EX-101.SCH) — 3KB
- ibo-20251024_lab.xml (EX-101.LAB) — 33KB
- ibo-20251024_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. IMPACT BIOMEDICAL INC. Date: October 27, 2025 By: /s/ Frank D. Heuszel Name: Frank D. Heuszel Title: Chief Executive Officer